AXSOME THERAPEUTICS INC. - COMMON STOCK
125,68
17-марта-25 16:45:00
15 мин. задержка
Акции
+3,77
+3,09%
Сегодняшний диапазон
121,90 - 126,94
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
16 сен 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
14 сен 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
23 авг 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
09 авг 2021 07:05:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Second Quarter 2021 Financial Results on August 9, 2021
15 июл 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia
15 июн 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
10 май 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
07 май 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021
27 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
26 апр 2021 06:00:00 Источник Nasdaq GlobeNewswire
-
01 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
19 фев 2021 07:00:00 Источник Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
16 фев 2021 07:00:02 Источник Nasdaq GlobeNewswire